LogicBio Therapeutics, Inc.·4

Oct 22, 9:22 PM ET

Poole Sandra 4

4 · LogicBio Therapeutics, Inc. · Filed Oct 22, 2018

Insider Transaction Report

Form 4
Period: 2018-10-18
Poole Sandra
Chief Operating Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2018-10-18+106,262106,262 total
    Exercise: $10.00Exp: 2028-10-17Common Stock (106,262 underlying)
Footnotes (1)
  • [F1]The option becomes exercisable in equal one forty-eighth installments from the vesting commencement date, October 18, 2018.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION